| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.3M | -18.1% |
| R&D Expense | $127.2M | +14.2% |
| SG&A Expense | $28.8M | -0.6% |
| Operating Income | -$139.6M | -15.9% |
| Interest Expense | $4.0M | +226.8% |
| Net Income | -$138.5M | -15.7% |
| EPS (Basic) | -$1.20 | +9.1% |
| EPS (Diluted) | -$1.20 | +9.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.0M | +13.5% |
| Short-term Investments | $16.3M | -86.0% |
| Current Assets | $87.4M | -52.2% |
| Total Assets | $177.8M | -26.2% |
| Current Liabilities | $27.3M | -21.4% |
| Long-term Debt | $40.1M | +107.5% |
| Total Liabilities | $125.9M | +80.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$121.6M | -4.9% |
| Capital Expenditures | $4.6M | -22.1% |
| Investing Cash Flow | $102.3M | +889.4% |
| Financing Cash Flow | $25.1M | -69.8% |
| Free Cash Flow | -$126.2M | -3.6% |
| Stockholders' Equity |
| $51.9M |
| -69.6% |